EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

H2-O deficiency in B cells or dendritic cells drives retrovirus-neutralizing antibody responses

Julie Dobkin, Ryan Fink, Helen Beilinson Lietuvninkas, Tatyana V Golovkina iD, Lisa K Denzin iD

Journal of Virology · 22.09.2026 · 100 (9)

DOI: 10.1128/jvi.00853-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 22.09.2026. Verfasst von Julie Dobkin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Dendritic Cells, B-Lymphocytes, Antibodies, Neutralizing, Histocompatibility Antigens Class II. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Institute of Allergy and Infectious Diseases, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major histocompatibility complex class II (MHC II)-restricted antigen presentation is central to CD4 + T-cell activation and the generation of high-affinity, class-switched antibody (Ab) responses. Peptide loading of MHC II in endosomal compartments is modulated by the functional interplay of two nonclassical MHC II molecules, H2-M and H2-O. H2-M binds to MHC II and facilitates loading of MHC II with high-affinity peptides. H2-O, a structural mimic of MHC II, modulates the MHC II pathway by binding to H2-M and inhibiting its peptide-loading catalytic activity. Although H2-O has a modest effect on the overall cell-surface MHC II peptide repertoire, these changes are sufficient to drive significant immunological consequences. H2-O plays a protective role against infection with ubiquitous γ-herpesviruses, while H2-O deficiency enables the development of protective, pathogen-specific Ab responses to mouse retroviruses and Staphylococcus aureus . Here, we further investigate the role of H2-O in regulating humoral immunity to a mouse retrovirus, mouse mammary tumor virus (MMTV). Using mosaic and conditional genetic approaches, we demonstrate that H2-O deficiency, and thus enhanced H2-M-mediated peptide loading, in either B cells or dendritic cells, is sufficient to drive a robust neutralizing Ab response against MMTV. Additionally, we show that the pronounced reduction of H2-O protein in germinal center B cells is governed by a post-transcriptional mechanism, revealing a previously unappreciated mechanism of H2-O regulation during the germinal center reaction. Collectively, these findings further establish H2-O as a tunable checkpoint in the MHC II antigen presentation pathway that shapes the quality of humoral immune responses. IMPORTANCE Protective antibody responses depend on the presentation of pathogen-derived peptides by major histocompatibility complex (MHC) class II molecules to activate CD4 + helper T cells. This process is tightly regulated. H2-O functions as a negative regulator of antigen presentation by limiting the repertoire of peptides displayed by MHC class II molecules, thereby shaping the antibody response. In this study, we show that the loss of H2-O in either of two key antigen-presenting cell types—B cells or dendritic cells—is sufficient to elicit a robust protective antibody response against a mouse retrovirus. We further demonstrate that germinal center B cells downregulate H2-O through protein degradation during the immune response. Together, these findings identify H2-O as a tunable checkpoint that regulates the magnitude and quality of antibody responses and provide additional evidence that B cells are key antigen-presenting cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsB-LymphocytesAntibodies, NeutralizingHistocompatibility Antigens Class IIAntibodies, ViralRetroviridaeH-2 AntigensAnimalsMiceAntigen PresentationMice, Inbred C57BLMice, Knockout

Stichwörter der Autor:innen

H2-OMHC II presenatationneutralizing antibody responsesviruses

Substanzen

Antibodies, NeutralizingHistocompatibility Antigens Class IIAntibodies, ViralH-2 Antigens

Autor:innen und Institutionen

  • Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • Microbiology & Molecular Genetics Program, Rutgers Graduate School of Biomedical Sciences, Piscataway, New Jersey, USA.
  • Molecular and Pharmacology Program, Rutgers Graduate School of Biomedical Sciences, Piscataway, New Jersey, USA.
  • Department of Microbiology, Committee on Microbiology, Committee on Immunology, Committee on Genetics, Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, USA.
  • Department of Pediatrics and Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

ORCID-Profile: Tatyana V Golovkina, Lisa K Denzin

Förderung

  • NCATS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NCI NIH HHS
  • NIAID NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Dobkin, J., Fink, R., Lietuvninkas, H. B., Golovkina, T. V., & Denzin, L. K. (2026). H2-O deficiency in B cells or dendritic cells drives retrovirus-neutralizing antibody responses. Journal of Virology, 100(9). https://doi.org/10.1128/jvi.00853-26

Vancouver

Dobkin J, Fink R, Lietuvninkas HB, Golovkina TV, Denzin LK. H2-O deficiency in B cells or dendritic cells drives retrovirus-neutralizing antibody responses. Journal of Virology. 2026;100(9). doi:10.1128/jvi.00853-26

BibTeX
@article{Dobkin2026,
  author = {Dobkin, Julie and Fink, Ryan and Lietuvninkas, Helen Beilinson and Golovkina, Tatyana V and Denzin, Lisa K},
  title = {H2-O deficiency in B cells or dendritic cells drives retrovirus-neutralizing antibody responses},
  journal = {Journal of Virology},
  year = {2026},
  volume = {100},
  number = {9},
  doi = {10.1128/jvi.00853-26}
}
Kostenlos starten →